All articles by Daniel Garrun

  1. Drugdevelopment-technology.com launches major industry survey

    Drugdevelopment-technology.com would like to invite you to take part in our latest industry confidence tracking survey, examining industry sentiment surrounding…
    Read More…

    16 Dec
  2. Breaking barriers – the potential of subcutaneous drug delivery

    In 2010, there were nearly 50,000 new cases of breast cancer alone in the UK, and the situation is only…
    Read More…

    16 Jun
  3. Imperial marches into Africa – building a drug supply chain

    PHD, the pharmaceutical distribution division of the RTT Group, is an innovative, multichannelled pharmaceutical distributor in Sub Saharan Africa. It…
    Read More…

    27 Nov
  4. The fake drug war: spotlight on Europe and the US

    The European Federation of Pharmaceutical Industries and Associations (EFPIA) reported that more than 11 million illegal medicines were stopped at…
    Read More…

    24 Sep
  5. Newest new markets: why API manufacturing is moving beyond India and China

    Taiwan – going global In recent years, the Government of Taiwan has invested more than $2.5bn into the local pharmaceutical…
    Read More…

    15 Aug
  6. Clinical trial delays: America’s patient recruitment dilemma

    Patient recruitment is absolutely essential to the success of pharmaceutical research, and consequently patient care, but today nearly 80% of…
    Read More…

    18 Jul
  7. Truvada – finally a pharmaceutical answer to HIV prevention?

    According to current Centers for Disease Control and Prevention (CDC) data, each year some 50,000 people are newly infected with…
    Read More…

    26 Jun
  8. One for all: the growth of interoperable data systems for clinical trials

    One of the most significant challenges facing the pharmaceutical community is the explosion of genomics and other ‘big data’. While…
    Read More…

    23 May
  9. Pinpoint accuracy: programmable nanoparticles and future cancer treatments

    Many drugs, including most cancer therapies, are distributed throughout the body immediately after administration, killing healthy cells at the same…
    Read More…

    17 May
  10. Small players, big drugs – pharmaceutical SMEs take the innovative edge

    Big Pharma has never been renowned for innovation. Rather, large pharmaceutical companies have traditionally focused on developing and testing conventional…
    Read More…

    18 Apr
Close
Close
Close

Go Top